A case of monosymptomatic hypochondriacal psychosis treated with olanzapine.
OBJECTIVE
To emphasize the availability of safer alternatives to currently standard therapy for monosymptomatic hypochondriacal psychosis (MHP).


METHODS
We report a case of treatment of monosymptomatic hypochondriacal psychosis in an elderly woman with the atypical neuroleptic olanzapine.


RESULTS
Treatment with rather low doses of olanzapine led to complete resolution of delusional symptoms.


CONCLUSIONS
Olanzapine, like other atypical neuroleptic agents, shows promise as a treatment for this syndrome, and it offers considerable safety and side-effect advantages over older agents.
Weintraub
E
E
University of Maryland Medical System, Baltimore, Maryland 21201, USA. EWeintra@UMPSY.UMaryland.edu
Robinson
C
C
D000368:Aged; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D001569:Benzodiazepines; D005260:Female; D006801:Humans; D006998:Hypochondriasis / Q000188:drug therapy* / Q000523:psychology; D000077152:Olanzapine; D010890:Pirenzepine / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D011618:Psychotic Disorders / Q000188:drug therapy* / Q000523:psychology; D016896:Treatment Outcome
D014150:Antipsychotic Agents; D001569:Benzodiazepines; D010890:Pirenzepine; D000077152:Olanzapine